ImmunoGen

USA

ImmunoGen

830 Winter Street

Daniel M. Junius — President and Chief Executive Officer
John M. Lambert, Ph.D. — Executive Vice President, Research and Development and Chief Scientific Officer
Charles Morris, M.B., Ch.B., M.R.C.P. — Executive Vice President and Chief Development Officer
Gregory Perry — Executive Vice President and Chief Financial Officer
Godfrey Amphlett, Ph.D. — Vice President, Process and Analytical Development
Craig Barrows — Vice President, General Counsel and Secretary
Robert J. Lutz, Ph.D. — Vice President, Translational Research and Development
James O`Leary, M.D. — Vice President and Chief Medical Officer
Peter Williams — Vice President, Business Development
Theresa Wingrove, Ph.D. — Vice President, Regulatory Affairs

Онкология

Производство

Рак крови, Рак щитовидной железы и др.эндокринных желез, Рак мужских половых органов, Рак женских половых органов, Рак молочной железы, Рак легкого, Рак кишечника, Рак желудка

IMGN

Stephen C. McCluski — Chairman
Daniel M. Junius
Mark Goldberg, M.D.
Dean Mitchell
Nicole Onetto, M.D.
Kristine Peterson
Howard H. Pien
Mark Skaletsky
Joseph J. Villafranca, Ph.D.
Richard J. Wallace

1.2400

Клеточные технологии, Моноклональные антитела, Приборы, Технологии, Фармацевтика, Химия